Investment and expertise
for promising, early-stage
Scottish technology and
life science companies.
WHAT WE DO
We are a prominent
business angel syndicate,
which has been at the
forefront of early stage
investing in Scotland for
more than two decades.
SEE OUR MEMBER BENEFITS
We invest in companies
from the technology,
software and life sciences
sectors – three markets in
which Scotland produces
a wealth of talent.
SEE IF YOU MEET THE CRITERIA

Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.

Latest News

Sorting:
  • Niki McKenzie: The Foundations of Building a Successful Start-up

    These top tips from Niki McKenzie, Investment Director at Archangels, make essential reading for ambitious entrepreneurs. I’m often asked for advice by start-up entrepreneurs as they set out to turn their business ideas into reality. As Investment Director at Archangels, which invests in early stage technology and life sciences businesses across Scotland, it comes with […]

  • New Archangels Board Member: Tim Allan

    Scottish Chambers of Commerce President Joins Archangels Board Tim Allan is joining the board of Archangels. He succeeds Alastair Salvesen CBE, whose retirement from the Archangels board, on which he has served for 10 years, is being announced at our annual Chorus event for investors and investee companies which takes place this evening (14th March, […]

  • Optoscribe Release New Ultra-High Speed 3D Photonic Manufacturing

    Our portfolio company Optoscribe Ltd has this week announced the release of its 3rd generation ultra-high-speed 3D photonic component manufacturing system and the expansion of its cleanroom within its state-of-the-art facility in Livingston, UK. The company, a world-leader in the delivery of high-volume laser-based manufacturing of 3D photonic integrated circuits, has also increased its headcount by […]

  • Blackford Analysis Recognised with F&S Visionary Innovation Leadership Award

    Our portfolio company Blackford Analysis, the medical imaging platform, announced that it has been recognised with the 2019 Visionary Innovation Leadership Award from analyst firm Frost & Sullivan. The healthcare technology company won the award for best practices in medical imaging artificial intelligence (AI) marketplace solutions. Blackford Platform™ provides centralised access to a marketplace of medical imaging […]

  • Optoscribe and Sumitomo Electric Announce Strategic Cooperation

      Our portfolio company Optoscribe and Sumitomo Electric have announced a strategic cooperation to deliver multicore fiber components.  Optoscribe, a world-leading supplier of 3D glass-based integrated photonics components and Sumitomo Electric Industries, a world-class optical fiber cable and component manufacturing technology supplier, are delighted to announce the formation of a strategic cooperation to provide multicore […]

  • Investigational New Drug Applications Cleared for MGB BioPharma

    Our portfolio company MGB BioPharma, a biopharmaceutical company who is developing a novel class of anti-infectives, to address the major global problem of antibiotic resistance, has today announced that the Food and Drug Administration (FDA) and Health Canada have cleared Investigational New Drug applications (IND/CTA) for its lead candidate. MGB-BP-3 is a novel antibiotic that targets Clostridium difficile-Associated Diarrhoea (CDAD).  The […]

Company portfolio

  • RT @OvensDavid: Nice to talk to @DJohnsonMSP today about the importance of angel investing to the Scottish economy and the great work which…
    Archangel Investors Ltd about 2 days ago

See our ‘Impact evaluation of activities report’ by the Hunter Centre for Entrepreneurship at The University of Strathclyde.